<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346114</id>
  <title nil="true"/>
  <common-name>2-(2,3-dichlorophenoxy)-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]acetamide</common-name>
  <description>2-(2,3-dichlorophenoxy)-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]acetamide is a chemical compound with the formula C27H24Cl2N4O3. With an average molecular weight of 523.40 g/mol, 2-(2,3-dichlorophenoxy)-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]acetamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>9611701</pubchem-id>
  <chemical-formula>C27H24Cl2N4O3</chemical-formula>
  <weight>523.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:26:40Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:26:40Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCOC1=CC=C(C=C1)C2=NN(C=C2C=NNC(=O)COC3=C(C(=CC=C3)Cl)Cl)C4=CC=CC=C4</moldb-smiles>
  <moldb-formula>C27H24Cl2N4O3</moldb-formula>
  <moldb-inchi>InChI=1S/C27H24Cl2N4O3/c1-2-15-35-22-13-11-19(12-14-22)27-20(17-33(32-27)21-7-4-3-5-8-21)16-30-31-25(34)18-36-24-10-6-9-23(28)26(24)29/h3-14,16-17H,2,15,18H2,1H3,(H,31,34)/b30-16+</moldb-inchi>
  <moldb-inchikey>CHZMYSNVJFWDTG-OKCVXOCRSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">522.122546</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342007</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-(2,3-dichlorophenoxy)-n-[(e)-[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylideneamino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Pyrazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296467</sync-id>
  <structure-inchikey>CHZMYSNVJFWDTG-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000004000000008800002000000000000000000000080400000000000000000000002000102300000000002002004000000000000000000810000000000000000000000400000000080000000000020000020000300000204000000000000000020010000000000000082000000800008080100008040020000000010000021004040000000800000000000000080800000100100000000000000000400000000000000000010000000080000002000000000090000000200040000000000000000000000000000000000000000000010000000000000000200000000000000000040000000001048000000000400000000080020000000080200000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:57Z</structure-indexed-at>
</compound>
